2020.Nov.06

Announcement of 2020 Q3 financial reports submitted to the board of directors

Date of the financial reports submitted to the board of directors or approved by the board of directors: Nov 06, 2020 Date of the financial reports approved by the audit committee: Nov 06, 2020 Year/Quarter of financial reports: 2020 Q3 Accumulated operating revenue in the reporting period (thousand NTD): 61,020 Accumulated gross profit (loss) from […]

HOMEWhat’s NewAnnouncementsAnnouncement of 2020 Q3 financial reports submitted to the board of directors

Back to List

This article is password protected.

To view the content, please enter your password in the field below

2020.Oct.15

OBI capital increases by issuance of stocks to transfer stocks with Amaran Biotechnology Inc. (the agreement of share exchange and cooperation signed, and trading counterparts designated)

2020.Nov.23

OBI received the reply from FDA about the Investigational Device Exemption (IDE) of Phase I/II Cohort Expansion human clinical studies for first-in-class novel prodrug, OBI-3424